20152019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Giuseppe Rospo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin

    Arena, S., Corti, G., Durinikova, E., Montone, M., Reilly, N. M., Russo, M., Lorenzato, A., Arcella, P., Lazzari, L., Rospo, G., Pagani, M., Cancelliere, C., Negrino, C., Isella, C., Bartolini, A., Cassingena, A., Amatu, A., Mauri, G., Sartore-Bianchi, A., Mittica, G. & 7 others, Medico, E., Marsoni, S., Linnebacher, M., Abrignani, S., Siena, S., Di Nicolantonio, F. & Bardelli, A., Dec 12 2019, In : Clin. Cancer Res..

    Research output: Contribution to journalArticle

  • Evolving neoantigen profiles in colorectal cancers with DNA repair defects

    Rospo, G., Lorenzato, A., Amirouchene-Angelozzi, N., Magrì, A., Cancelliere, C., Corti, G., Negrino, C., Amodio, V., Montone, M., Bartolini, A., Barault, L., Novara, L., Isella, C., Medico, E., Bertotti, A., Trusolino, L., Germano, G., Di Nicolantonio, F. & Bardelli, A., Jun 28 2019, In : Genome Medicine. 11, 1, p. 42

    Research output: Contribution to journalArticle

  • Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses: A Phase 2 Randomized Clinical Trial

    Montagut, C., Argilés, G., Ciardiello, F., Poulsen, T. T., Dienstmann, R., Kragh, M., Kopetz, S., Lindsted, T., Ding, C., Vidal, J., Clausell-Tormos, J., Siravegna, G., Sánchez-Martín, F. J., Koefoed, K., Pedersen, M. W., Grandal, M. M., Dvorkin, M., Wyrwicz, L., Rovira, A., Cubillo, A. & 12 others, Salazar, R., Desseigne, F., Nadal, C., Albanell, J., Zagonel, V., Siena, S., Fumi, G., Rospo, G., Nadler, P., Horak, I. D., Bardelli, A. & Tabernero, J., Apr 12 2018, In : JAMA oncology. 4, 4, p. e175245

    Research output: Contribution to journalArticle

  • Efficacy of Sym004 in patients with metastatic colorectal cancer with acquired resistance to anti-EGFR therapy and molecularly selected by circulating tumor DNA analyses a phase 2 randomized clinical trial

    Montagut, C., Argilés, G., Ciardiello, F., Poulsen, T. T., Dienstmann, R., Kragh, M., Kopetz, S., Lindsted, T., Ding, C., Vidal, J., Clausell-Tormos, J., Siravegna, G., Sánchez-Martín, F. J., Koefoed, K., Pedersen, M. W., Grandal, M. M., Dvorkin, M., Wyrwicz, L., Rovira, A., Cubillo, A. & 12 others, Salazar, R., Desseigne, F., Nadal, C., Albanell, J., Zagonel, V., Siena, S., Fumi, G., Rospo, G., Nadler, P., Horak, I. D., Bardelli, A. & Tabernero, J., Apr 1 2018, In : JAMA oncology. 4, 4, e175245.

    Research output: Contribution to journalArticle